Tracking insulin- and glucagon-expressing cells in vitro and in vivo using a double reporter human embryonic stem cell line

Samantha Mar,Ekaterina Filatov,Shugo Sasaki,Majid Mojibian,Dahai Zhang,Angela Yang,Cuilan Nian,Francis C Lynn
DOI: https://doi.org/10.2337/db24-0756
IF: 7.7
2024-11-24
Diabetes
Abstract:Human embryonic stem cell (hESC)-derived pancreatic alpha and beta cells can be used to develop cell replacement therapies to treat diabetes. However, recent published differentiation protocols yield varying amounts of alpha and beta cells amidst heterogeneous cell populations. To visualize and isolate hESC-derived alpha and beta cells, we generated a GLUCAGON-2AmScarlet and INSULIN-2A-EGFP dual fluorescent reporter (INSEGFPGCGmScarlet) hESC line using CRISPR/Cas9. We established robust...
endocrinology & metabolism
What problem does this paper attempt to address?